Table 1.
Virus family | Virus Name | Viral factorsa | Cellular proteinsb | Effects on the host and/or the virus | References |
---|---|---|---|---|---|
Flaviviridae | DENV | Capsid | [41], [42] | ||
WNV | Capsid (123 aa) | HDM2, DDX56, Jab1 | DDX56 important for virus infectivity HDM2 localized in the nucleolus and induction of p53-dpt apoptosis Jab1 protects cells against the capsid cytoxic effects |
[43], [44], [60], [61] | |
JEV | Capsid | B23 | B23 important for virus replication | [45], [130] | |
Kunjin virus | Capsid | [46] | |||
HCV | Core, NS5B? | Nucleolin, B23, PKR | Upregulation of B23 synthesis via reduction of YY1 repressive activity on B23 promoter NCL is important for virus replication NCL found at HCV IRES |
[36], [37], [38], [53], [62], [63], [70], [131] | |
Coronaviridae | SARS-CoV | 3b, Nucleocapsid | B23 | Inhibition of B23 phosphorylation | [31], [32], [39], [40], [132] |
Avian IBV | Nucleocapsid | Nucleolin, p53 | Alteration of fibrillarin localization p53 delocalized in the perinuclear region Inhibition of cell growth |
[47], [48], [133], [134] | |
Arteriviridae | PPRSV | Nucleocapsid | Fibrillarin, HIC | Mutation of N prevents its nucleolar localization reduces viral replication in vitro, delays viremia and increases NAb titers in vivo. | [17], [49], [51], [52], [135] |
Togaviridae | SFV | nsP2, capsid | Mutation of nsP2 prevents its nuclear localization and reduces viral spread and neurovirulence in vivo | [34], [35], [57], [73], [74], [75], [76], [136] | |
GETV M1 | P21waf | S-phase arrest and apoptosis in glioma cells | [72] |
Viral proteins shown to localize in the nucleolus.
Nucleolar proteins interacting with viral factor or cellular, non nucleolar proteins shown to be translocated into the nucleolus by the virus or the viral proteins.